Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions)	2014			2013			2014			2013
				(restated)						(restated)
Net sales
Interventional Cardiology	$	514		$	474		$	1,543		$	1,493
Peripheral Interventions	217			200			631			597
Cardiovascular	731			674			2,174			2,090
Cardiac Rhythm Management	482			465			1,441			1,416
Electrophysiology	54			35			167			105
Rhythm Management	536			500			1,608			1,521
Endoscopy	340			319			990			939
Urology and Women's Health	138			131			397			372
Neuromodulation	115			116			338			316
MedSurg	593			566			1,725			1,627
Net sales allocated to reportable segments	1,860			1,740			5,507			5,238
Sales generated from divested businesses	1			2			4			57
Impact of foreign currency fluctuations	(15		)	(7		)	(18		)	10
	$	1,846		$	1,735		$	5,493		$	5,305
Income (loss) before income taxes
Cardiovascular	$	201		$	175		$	565		$	515
Rhythm Management	76			63			209			176
MedSurg	192			176			535			487
Operating income allocated to reportable segments	469			414			1,309			1,178
Corporate expenses and currency exchange	(90		)	(78		)	(205		)	(168		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges or credits	(206		)	(132		)	(586		)	(711		)
Amortization expense	(109		)	(101		)	(327		)	(305		)
Operating income (loss)	64			103			191			(6		)
Other expense, net	(61		)	(143		)	(146		)	(276		)
Income (loss) before income taxes	$	3		$	(40	)	$	45		$	(282	)